ARCHIVES

Xgeva Delays Metastases To Bone, Amgen Files To Expand Indication

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication

November 18, 2011

New “JNC” Popular Replacement For Old Journals

May 20, 1988

Cancer Policy: Board Plans Paper On Tobacco Control

June 13, 1997

House Committee Alleges Irregularities In Tamoxifen Trial Informed Consent Forms

October 30, 1992

Private Sector Still Valuable To National Cancer Program, ACS Research Chief Says

April 26, 1974

Quality of Care: ASCO Publishes “Top Five” Ways to Improve Cancer Care

November 1, 2013